What type of study is this?

This is a Experimental Study study (also classified as: Animal Study).

September 27, 2025Cancer Research

Abstract B017: Precision Nanotherapy for the Treatment of Progressive Neuroblastoma

View Full Paper

Ask AI

Bookmark

Authors

LPLoganayaki PeriyasamyOklahoma State University PSPoorvi SubramanianOklahoma State University SASheeja AravindanDr. R. Ahmed Dental College and Hospital

Discussion

Member takes

Implication

This research uncovers targeted nanotherapy's ability to reduce tumor volume in progressive neuroblastoma, suggesting a new direction in pediatric cancer treatment.

Key Points

Nanotherapy demonstrates substantial reduction in tumor volume in progressive neuroblastoma, indicating its promising efficacy.
Five unique RD3 peptides were synthesized and assessed, showing significant anti-tumor effects compared to control treatments.
Xenografts in athymic nude mice treated with RD3Þ[GD2]IL showed effective tumor regression without notable toxicity to normal tissues.
Targeted therapy with RD3Þ[GD2]IL-3 may redefine treatment options for progressive neuroblastoma where current therapies fail.

Cite This Study

Periyasamy et al. (2025) studied this question.

synapsesocial.com/papers/68d7b3ddeebfec0fc523661e https://doi.org/10.1158/1538-7445.pediatric25-b017

View Full Paper

Ask AI

Bookmark

Implication

This research uncovers targeted nanotherapy's ability to reduce tumor volume in progressive neuroblastoma, suggesting a new direction in pediatric cancer treatment.

Abstract B017: Precision Nanotherapy for the Treatment of Progressive Neuroblastoma

Discussion

Member takes

Implication

Key Points

Cite This Study

Abstract B017: Precision Nanotherapy for the Treatment of Progressive Neuroblastoma

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider